Search

Medtronic PLC

Slēgts

SektorsVeselības aprūpe

95.38 -1.25

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

95.38

Max

96.86

Galvenie mērījumi

By Trading Economics

Ienākumi

206M

1.5B

Pārdošana

-51M

9.8B

P/E

Sektora vidējais

22.794

49.241

EPS

1.45

Dividenžu ienesīgums

3.01

Peļņas marža

15.16

Darbinieki

95,000

EBITDA

47M

2.7B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+8.15% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

3.01%

2.15%

Nākamie ieņēmumi

2026. g. 17. nov.

Nākamais dividenžu datums

2027. g. 15. janv.

Nākamais Ex dividenžu datums

2026. g. 25. dec.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

2.6B

119B

Iepriekšējā atvēršanas cena

96.63

Iepriekšējā slēgšanas cena

95.38

Medtronic PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 23. okt. 23:01 UTC

Medtronic PLC shares advanced in after-market trading, supported by a notable rise in the Health Care Equipment sub-sector.

2026. g. 22. okt. 23:41 UTC

Event

Medtronic PLC announced positive real-world registry results for its Affera™ Mapping and Ablation System and Sphere-9™ Catheter, along with the PulseSelect™ PFA System.

2026. g. 21. okt. 20:02 UTC

News

Medtronic PLC shares declined sharply, retracing from an early high and hitting a mid-afternoon low, amid high market volume.

2026. g. 20. okt. 21:03 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from a brief high shortly after the market closed.

2026. g. 19. okt. 23:01 UTC

News

Medtronic PLC appointed Michael Marinaro as President, effective October 14, 2026, with a $1M salary and $3.25M in long-term incentives.

2026. g. 16. okt. 20:07 UTC

Medtronic PLC shares are modestly lower, following a broader market decline of nearly three-quarters of a percent since Thursday's close.

2026. g. 15. okt. 20:07 UTC

News

Medtronic PLC completed the separation of MiniMed Group, Inc., exchanging 252.81M shares of MiniMed for 55.03M of its own ordinary shares.

2026. g. 14. okt. 23:01 UTC

Medtronic PLC shares are trading lower in after-market hours, having pulled back from earlier gains, now near the lower end of today’s range.

2026. g. 13. okt. 23:01 UTC

Medtronic PLC shares declined in after-market hours, reversing from earlier gains to a modest loss since Tuesday's close.

2026. g. 12. okt. 22:01 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from earlier gains.

2026. g. 9. okt. 21:01 UTC

Medtronic PLC shares are trading modestly higher in after-market hours, following a pullback earlier in the session and three consecutive sessions of gains.

2026. g. 8. okt. 23:05 UTC

Medtronic PLC saw a modest increase in after-market trading, recovering from earlier lows while remaining below its 20-day moving average.

2026. g. 7. okt. 22:51 UTC

News

Medtronic PLC announced an exchange ratio of 4.5939 shares of MiniMed Group, Inc. stock for each ordinary share, contributing to a modest gain in after-market trading.

2026. g. 6. okt. 22:40 UTC

Medtronic PLC is recovering in after-market trading, rising sharply from Tuesday's close and reaching its highest level of the day, despite remaining below its 20-day moving average.

2026. g. 5. okt. 21:01 UTC

Medtronic PLC traded roughly flat during after-market hours, closing near the lower end of its one-month range and below its 20-day moving average.

2026. g. 3. okt. 00:00 UTC

Medtronic PLC shares traded modestly higher in after-market hours on Friday, recovering from a brief dip and remaining near the lower end of their one-month trading range.

2026. g. 2. okt. 23:00 UTC

Medtronic PLC is advancing in after-market trading, showing a modest increase since Friday's close, with significant upward movement shortly after the market reopened.

2026. g. 1. okt. 22:01 UTC

News

Medtronic PLC shares are higher in after-market trading following the approval of new CPT codes for its Altaviva and Symplicity Spyral devices, effective January 2028.

2026. g. 30. sept. 23:01 UTC

Medtronic PLC is trading modestly higher in after-market hours, reflecting broader market trends amid positive economic indicators and stronger-than-expected private sector job growth.

2026. g. 29. sept. 20:02 UTC

Medtronic PLC shares fell sharply today, reversing a trend of higher daily closes, amid unusually high trading volume and broader market trends.

2026. g. 28. sept. 23:16 UTC

Medtronic PLC is trading slightly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

2026. g. 25. sept. 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

2026. g. 23. sept. 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

2026. g. 22. sept. 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

2026. g. 21. sept. 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

2026. g. 18. sept. 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

2026. g. 17. sept. 23:06 UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

2026. g. 16. sept. 23:01 UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

2026. g. 15. sept. 23:01 UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

2026. g. 14. sept. 23:06 UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

Salīdzinājums

Cenas izmaiņa

Medtronic PLC Prognoze

Cenas mērķis

By TipRanks

8.15% augšup

Prognoze 12 mēnešiem

Vidējais 103.188 USD  8.15%

Augstākais 118 USD

Zemākais 85 USD

Pamatojoties uz 19 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Medtronic PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

19 ratings

10

Pirkt

9

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat